This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in JAMA  Topic Collections  • Psychiatry  • Depression  • Alert me on articles by topic  Social Bookmarking   What's this?

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In Reply: We concur with the number needed to treat of 10 that Dr Mathews and colleagues computed; this same number appears in the original article on page 1037. The exclusion of zero in the 95% CIs calculated by Mathews et al could be viewed as a validation of our statistically significant results.

Mathews et al and and Dr Price are concerned about our ITT analysis. Furthermore, Price and Mr Spielmans are concerned about the clinical relevance of our end point. To answer these concerns, we have reanalyzed the data with respect to the CDRS-R response and have included all randomized patients as well as various levels of response criteria (Table 1). These results show that inclusion of all patients in the ITT analysis, in fact, favor sertraline and that the significance of the responder analyses was not confined to the 40% criterion. We acknowledged modifications to the . . . [Full Text of this Article]

Karen D. Wagner, MD, PhD
University of Texas Medical Branch
Galveston

Christopher J. Wohlberg, MD, PhD; Ruoyong Yang, PhD
Pfizer Inc
New York, NY

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLES

Efficacy of Sertraline in the Treatment of Children and Adolescents With Major Depressive Disorder
Maju Mathews, Manu Mathews, and Joanne Mathews
JAMA. 2004;291(1):40.
EXTRACT | FULL TEXT  

Efficacy of Sertraline in the Treatment of Children and Adolescents With Major Depressive Disorder
David Price
JAMA. 2004;291(1):40-41.
EXTRACT | FULL TEXT  

Efficacy of Sertraline in the Treatment of Children and Adolescents With Major Depressive Disorder
Glen I. Spielmans
JAMA. 2004;291(1):41.
EXTRACT | FULL TEXT  

Efficacy of Sertraline in the Treatment of Children and Adolescents With Major Depressive Disorder
Antal E. Solyom
JAMA. 2004;291(1):41-42.
EXTRACT | FULL TEXT  

Efficacy of Sertraline in the Treatment of Children and Adolescents With Major Depressive Disorder: Two Randomized Controlled Trials
Karen Dineen Wagner, Paul Ambrosini, Moira Rynn, Christopher Wohlberg, Ruoyong Yang, Michael S. Greenbaum, Ann Childress, Craig Donnelly, and Deborah Deas
JAMA. 2003;290(8):1033-1041.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Sertraline and Depression in Children--Reply
Wagner et al.
JAMA 2004;291:1561-1562.
FULL TEXT